Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy
- 31 October 2005
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 95 (4) , 361-371
- https://doi.org/10.1016/s1081-1206(10)61155-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Economic and quality-of-life impact of seasonal allergic conjunctivitis in OxfordshireOphthalmic Epidemiology, 2004
- Ocular Allergic Disease: Mechanisms, Disease Sub-types, TreatmentThe Ocular Surface, 2003
- Direct costs of allergic rhinitis in the united states: Estimates from the 1996 medical expenditure panel surveyJournal of Allergy and Clinical Immunology, 2003
- Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF‐36Allergy, 2002
- Impact of Allergic Rhinitis Treatment on Quality of LifePharmacoEconomics, 2001
- Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and ImmunologyAnnals of Allergy, Asthma & Immunology, 1998
- Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of RhinitisAnnals of Allergy, Asthma & Immunology, 1998
- Prevalence of allergic rhinitis in the United StatesJournal of Allergy and Clinical Immunology, 1997
- Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitisClinical and Experimental Allergy, 1991